Fairview Pharmacy Services, LLC

Form 483 issued April 18, 2018 · Minneapolis, Minnesota

Inspection
Apr 2 – Apr 18, 2018
Observations
6
Pages
4
FEI number
3013468187

In short: On April 18, 2018, FDA issued a Form 483 with 6 observations to Fairview Pharmacy Services, LLC in Minneapolis, Minnesota (FEI 3013468187) after an inspection that ran Apr 2 – Apr 18, 2018. The investigators were Anthony Ladner and Tenzin Jangchup. Most observations concern production; the most-cited regulation is 21 CFR 211.113 (control of microbiological contamination).

At a glance

6 of 6 observations on this 483 concern production.

Production6

Most cited: 21 CFR 211.113 (6×) · 211.67 (1×)

What FDA observed

Preview: the opening words of each observation

Dashed: section inferred by FDA Intel and checked against the regulation text

  1. 01

    Non-sterilized and Non-depyrogenated equipment was used…

  2. 02

    The use of sporicidal agents in the cleanrooms and ISO 5 classified aseptic…

  3. 03

    Personnel did not disinfect and change gloves frequently…

  4. 04

    Disinfecting agents and cleaning wipes used in the ISO 5 classified aseptic processing…

2 more observations

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Fairview Pharmacy Services, LLC?

FDA listed 6 observations on this Form 483, mostly about production. The most-cited regulation is 21 CFR 211.113 (control of microbiological contamination). The opening words of each observation are shown on this page.

Who inspected Fairview Pharmacy Services, LLC?

Anthony Ladner and Tenzin Jangchup are named on this Form 483, for the inspection of Apr 2 – Apr 18, 2018. Each investigator has a profile showing what they cite most.

When was Fairview Pharmacy Services, LLC inspected by FDA?

The inspection ran Apr 2 – Apr 18, 2018, and the Form 483 is dated April 18, 2018.

How do I get the full Form 483 for Fairview Pharmacy Services, LLC?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free